Health In Tech, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing unaudited financial statements and management commentary covering the first nine months of its fiscal year.
Key Highlights
- Share count: As of November 11, 2026, the company had 67,086,059 shares of Class A common stock and 12,600,000 shares of Class B common stock outstanding, each with a par value of $0.001 per share.
- Cash position: Cash and cash equivalents stood at $10,127,237 as of September 30, 2026, compared with $7 million (figure partially truncated in source) as of December 31, 2025.
- Filer status: The company is designated as a non-accelerated filer, a smaller reporting company, and an emerging growth company under SEC definitions.
- Listing compliance risk noted: The filing lists as a forward-looking subject "our ability to regain and maintain compliance with The Nasdaq Stock Market LLC continued listing requirements."
- Exchange and ticker: Class A common stock trades on The Nasdaq Stock Market LLC under the symbol HIT (NASDAQ:HIT).
- Reporting period: The quarterly report covers the three and nine months ended September 30, 2026, with comparative periods for 2025.
Health In Tech Reports Q3 2026 Financial Position and Operational Disclosures
Health In Tech, Inc. (NASDAQ:HIT), incorporated in Nevada and headquartered at 701 S. Colorado Ave, Suite 1, Stuart, FL 34994, submitted its Form 10-Q for the quarterly period ended September 30, 2026. According to the filing, the company operates a platform business and disclosed unaudited consolidated balance sheets, statements of operations, statements of changes in stockholders' equity, and statements of cash flows covering both the three-month and nine-month periods ending September 30, 2026 and 2025.
The filing disclosed that cash and cash equivalents totaled $10,127,237 as of September 30, 2026. The company reported two classes of common stock: Class A common stock with 67,086,059 shares outstanding and Class B common stock with 12,600,000 shares outstanding as of November 11, 2026, both carrying a par value of $0.001 per share. The filing noted that the company has elected not to use the extended transition period for complying with new or revised financial accounting standards as permitted for emerging growth companies.
Among the forward-looking subjects identified by the company, the filing specifically calls out the ability to attract new customers to its platforms, to develop and enhance products and services, and to comply with applicable laws and regulations. The filing also identifies risks related to cybersecurity incidents, use of third-party artificial intelligence, and protection of intellectual property covering its platform and technology. All forward-looking statements in the filing are the company's own and are expressly subject to its cautionary language regarding known and unknown risks and uncertainties.
What Was Disclosed
Health In Tech, Inc. filed a Form 10-Q for the quarter ended September 30, 2026, reporting $10,127,237 in cash and cash equivalents, two classes of common stock totaling approximately 79.7 million shares outstanding, and emerging growth company status. The filing also identified Nasdaq listing compliance and platform growth as key forward-looking subjects for investors to consider alongside the company's cautionary disclosures.



Please wait processing your request...